Report copyright - Treating older patients with AML 2012 Istanbul · AML"17" Addi5on"of"gemtuzumab(GO)! Patients aged 50-70 yrs with de novo AML (N = 278) GO 3 mg/m2/day on Days 1, 4, and 7 + Daunorubicin
Please pass captcha verification before submit form